Tag: Shilpa Biologicals

Biopharma innovators must widen CDMO networks to accelerate development’ says Shilpa Biologicals ahead of BIO San Diego

28 May 2026 No Comments

Too many biotechs rely too narrowly on large CDMOs and engage too late, increasing

Shilpa Biologicals and mAbTree Biologics Secure Orphan Drug Designation from U.S. FDA

19 March 2026 No Comments

Marks significant milestone for breakthrough biologic to treat rare blood cancers Basel, Switzerland and